SEATTLE, March 10 /PRNewswire/ -- The Washington Biotechnology & Biomedical Association (WBBA) announced today the complete roster of companies to present at the annual Invest Northwest Life Science CEO & Investor Forum (Invest Northwest) scheduled for March 21-22. The finalists are public and private medical device and biotechnology companies selected from the four states and two Canadian provinces of the Pacific Northwest.
Presenting companies for Invest Northwest 2006 are: -- Accium BioSciences Inc. -- Seattle, WA -- Acucela Inc. -- Seattle, WA -- Alder Biotherapeutics -- Bothell, WA -- Allon Therapeutics -- Vancouver, BC -- AnorMED Inc. -- Langley, BC -- Calypso Medical Technologies -- Seattle, WA -- Cardiac Science -- Bothell, WA -- CardioMetrix -- Bothell, WA -- Cell Therapeutics Inc. -- Seattle, WA -- CEPTYR -- Bothell, WA -- Chemokine Therapeutics Corp. -- Vancouver, BC -- CombiMatrix Corporation -- Mukilteo, WA -- Corus Pharma Inc. -- Seattle, WA -- Dendreon Corporation -- Seattle, WA -- enGene Inc. -- Vancouver, BC -- Epigenomics AG -- Berlin, Germany -- GeneLex Corporation -- Bothell, WA -- GenoLogics Life Sciences -- Victoria, BC -- Hemcon, Inc. -- Portland, OR -- Helix Biomedix, Inc. -- Bothell, WA (Bulletin Board;HXBM; OB) -- iCo Therapeutics Inc. -- Vancouver, BC -- ICOS Corporation -- Bothell, WA -- Ikaria Inc. -- Seattle, WA -- Illumigen Biosciences Inc. -- Seattle, WA -- Inflazyme Pharmaceuticals Ltd. -- Richmond, BC -- Inovise Medical Inc. -- Portland, OR -- Koronis Pharmaceuticals -- Seattle, WA -- Light Sciences Corporation -- Snoqualmie, WA -- LigoCyte Pharmaceuticals, Inc. -- Bozeman, MT -- LipoSonix Inc. -- Bothell, WA -- Micronics -- Redmond, WA -- MIGENIX -- Vancouver, BC -- Neurocom International Inc. -- Clackamas, OR -- NeuroMed Technologies Inc. -- Vancouver, BC -- Nura Inc. -- Seattle, WA -- OncoGenex Technologies Inc. -- Vancouver, BC -- Oncolytics Biotech Inc. -- Calgary, AB -- Pathway Medical Technologies Inc. -- Redmond, WA -- PriTest Inc. -- Redmond, WA -- Protox Therapeutics, Inc. -- Vancouver, BC -- Response Biomedical Corporation -- Burnaby, BC -- Sangretech Biomedical -- Seattle, WA -- SCOLR Pharma, Inc. -- Bellevue, WA -- Seattle Genetics Inc. -- Bothell, WA -- SonoSite -- Bothell, WA -- Sonus Pharmaceuticals Inc. -- Bothell, WA -- Sound Pharmaceuticals -- Seattle, WA -- Spiration Inc. -- Redmond, WA -- Targeted Genetics Corporation -- Seattle, WA -- Trubion Pharmaceuticals Inc. -- Seattle, WA -- Twinstrand Therapeutics Inc. -- Burnaby, BC -- VisionGate Inc. -- Gig Harbor, WA -- VizX Labs LLC -- Seattle, WA -- VSM MedTech Ltd. -- Coquitlam, BC -- Xenon Pharmaceuticals Inc. -- Burnaby, BC -- Xillix Technologies Corp. -- Richmond, BC -- ZymoGenetics Inc. -- Seattle, WA
In addition to the 57 company presentations, keynote speaker will be Scott Gottlieb, MD, the U.S. Food & Drug Administration Deputy Commissioner, along with seven panel discussions topics.
In its fifth year, Invest Northwest is produced by the Washington Biotechnology & Biomedical Association in collaboration with BC Biotech, BC Medtech, BioAlberta, BioIdaho, Montana BioScience Alliance and the Oregon Bioscience Association.
Members of the media, professional investment community and bioscience leaders are invited to register online at www.washbio.org. Online registration deadline is March 15.
Platinum Partners for Invest Northwest 2006 are DLA Piper Rudnick Gray Cary and Moss Adams LLP.
For further information, contact: Washington Biotechnology & Biomedical Association Pam Love, 206.624.1967 pamlove@washbio.org
The Washington Biotechnology & Biomedical Association
CONTACT: Pam Love of Washington Biotechnology & Biomedical Association,+1-206-624-1967, or pamlove@washbio.org
Web site: http://www.washbio.org/
